Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Quadrivalent meningococcal conjugate vaccines

Registered for use in people aged 9 months to 55 years.

MenACWY-D — quadrivalent meningococcal (serogroups A, C, W, Y)–diphtheria toxoid conjugate vaccine

Each 0.5 mL monodose vial contains:

  • 4 µg meningococcal polysaccharide serogroup A
  • 4 µg meningococcal polysaccharide serogroup C
  • 4 µg meningococcal polysaccharide serogroup W
  • 4 µg meningococcal polysaccharide serogroup Y
  • 48 µg diphtheria toxoid protein

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Page history

Last updated: 
27 September 2021
Last reviewed: 
27 September 2021